Weekly and monthly subcutaneous buprenorphine depot formulations vs daily sublingual buprenorphine with naloxone for treatment of opioid use disorder a randomized clinical trial
- Michelle R. Lofwall
- , Sharon L. Walsh
- , Edward V. Nunes
- , Genie L. Bailey
- , Stacey C. Sigmon
- , Kyle M. Kampman
- , Michael Frost
- , Fredrik Tiberg
- , Margareta Linden
- , Behshad Sheldon
- , Sonia Oosman
- , Stefan Peterson
- , Michael Chen
- , Sonnie Kim
Producción científica: Article › revisión exhaustiva
240
Citas
(Scopus)